Theracell Advanced Biotechnology (BELGIUM) (SRL)

Active
VAT

BE 0731.712.273

Address
Aye Rue de la Science 8
6900 Marche-en-Famenne
Established
30-07-2019
Principal activity
Other research and experimental development on natural sciences and engineering

Crisis resilience of Theracell Advanced Biotechnology (BELGIUM)

Which companies are best armed against current economic trends and the energy crisis?

Read more

Financial data of Theracell Advanced Biotechnology (BELGIUM)

2022 Financial statements 2021 Financial statements 2020 Financial statements
Profit/Loss -€128,310
-92%
-€66,861
< -1.000%
-€2,504
Equity -€179,076
-253%
-€50,765
-415%
€16,096
Gross margin -€37,200
-273%
-€9,979
-455%
-€1,800
Employees 1,6 FTE
0%
1,6 FTE
-
-

Frequently asked questions

What is the VAT number of Theracell Advanced Biotechnology (BELGIUM)?
The VAT number of Theracell Advanced Biotechnology (BELGIUM) is BE0731712273.
When was Theracell Advanced Biotechnology (BELGIUM) founded?
Theracell Advanced Biotechnology (BELGIUM) was founded on 30-07-2019.
What is the address of Theracell Advanced Biotechnology (BELGIUM)?
The current registered office of Theracell Advanced Biotechnology (BELGIUM) is located at Aye Rue de la Science 8, 6900 Marche-en-Famenne.
When was the last time Theracell Advanced Biotechnology (BELGIUM) filed their annual financial statements?
The most recent financial statements of Theracell Advanced Biotechnology (BELGIUM) were filed on 14-07-2023. You can view them here.
How many employees does Theracell Advanced Biotechnology (BELGIUM) have?
There are 1,6 FTEs working at Theracell Advanced Biotechnology (BELGIUM) according to the staff figures in the most recent financial statements.
What is the annual turnover of Theracell Advanced Biotechnology (BELGIUM)?
At the time of its most recent financial statements, Theracell Advanced Biotechnology (BELGIUM) did not publish any turnover figures. Theracell Advanced Biotechnology (BELGIUM) reported a gross margin of -€37,200.17.
Address

  You have disabled Javascript on your computer. To use this website, please enable Javascript first.


More details